CLINICAL_TRIALS
research
· 2025-01-01
Clinical Trial Update: Antifungal Drugs in Pulmonary Mucormycosis [Phase 4]
Summary
Phase 4 clinical trial update studying antifungal drugs for pulmonary mucormycosis, currently not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bin Cao | Conditions: Pulmonary Mucormycosis | Phase 4 | Status: NOT_YET_RECRUITING